REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations
NCT00121056 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2008-12-05
Summary
The purpose of this study is to determine if Enbrel® or Kineret® will have a positive effect on subject functionality as measured by the Health Assessment Questionnaire Disability Index (HAQDI).
Conditions
Interventions
- DRUG
-
Enbrel®
- DRUG
-
Kineret®
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
MD · Amgen
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-09-30
More Related Trials
-
Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis
NCT01394913 ·Status: WITHDRAWN ·Phase: PHASE3
-
Rheumatoid Arthritis DMARD Intervention and UtilizationStudy
NCT00116727 ·Status: COMPLETED
-
Study Evaluating Enbrel in Patients With Rheumatoid Arthritis
NCT00245934 ·Status: COMPLETED
-
Safety Study of a Single Dose of REGN88(SAR153191)in Patients With Rheumatoid Arthritis
NCT01055899 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating Kineret® (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using aSelf-Reported Questionnaire
NCT00121043 ·Status: COMPLETED ·Phase: PHASE4
-
Enbrel Liquid Immunogenicity Protocol
NCT00249041 ·Status: COMPLETED ·Phase: PHASE3
-
Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA)
NCT00117091 ·Status: COMPLETED ·Phase: PHASE3
-
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
NCT01313208 ·Status: COMPLETED ·Phase: PHASE4
-
Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab
NCT01981473 ·Status: COMPLETED
-
Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
NCT00001291 ·Status: COMPLETED
-
Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg
NCT00195338 ·Status: COMPLETED
-
Information and Acceptability of Biosimilars
NCT04321291 ·Status: UNKNOWN ·Phase: NA
-
Effects of Interleukin-1 Inhibition on Vascular and Left Ventricular Function in Rheumatoid Arthritis Patients With Coronary Artery Disease
NCT01566201 ·Status: COMPLETED ·Phase: NA
-
Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study
NCT01033656 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of the Clinical and Medico-economic Impact of SinnoTest® in Patients With Rheumatoid Arthritis
NCT04117165 ·Status: WITHDRAWN ·Phase: NA
-
Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis
NCT00078793 ·Status: COMPLETED
-
Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
NCT01188655 ·Status: COMPLETED
-
Prospective Evaluation of the Radiographic Efficacy of Enbrel
NCT01623752 ·Status: COMPLETED
-
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
NCT03414502 ·Status: RECRUITING ·Phase: PHASE3
-
A Multiple-dose Study of the Safety and Tolerability of REGN88(SAR153191) in Rheumatoid Arthritis Subjects
NCT01011959 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects
NCT00706797 ·Status: TERMINATED ·Phase: PHASE4
-
Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA Patients
NCT01270997 ·Status: COMPLETED ·Phase: PHASE3
-
COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA
NCT03649061 ·Status: COMPLETED ·Phase: PHASE4
-
MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE
NCT03355482 ·Status: TERMINATED ·Phase: PHASE2
-
Network to Understand Reproductive Rheumatology Registry
NCT06940869 ·Status: ENROLLING_BY_INVITATION